ArticleOncology letters2016

Neutrophil to lymphocyte ratio in the pre-treatment phase of final-line chemotherapy predicts the outcome of patients with recurrent ovarian cancer.

Keiichiro Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.